ArticleInternational journal of endocrinology2023

Effects of a Novel Glucokinase Activator, Dorzagliatin, on Glycemic Control and Glucose Fluctuation in Drug-Naïve Patients with Type 2 Diabetes Mellitus.

Yuming Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.